Drug Profile


Alternative Names: PLA-695

Latest Information Update: 05 Oct 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Analgesics; Antirheumatics; Benzoic acids
  • Mechanism of Action Phospholipase A2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Rheumatoid arthritis

Most Recent Events

  • 14 Jun 2008 Preclinical pharmacodynamics data in Rheumatoid arhtritis presented at the Annual European Congress of Rheumatology (EULAR-2008)
  • 31 Dec 2006 Phase-I clinical trials in Rheumatoid arthritis in USA (PO)
  • 31 Dec 2006 Phase-I clinical trials in Rheumatoid arthritis in Canada (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top